Early Treatment of Multisystem Inflammatory Syndrome in Children

• Published in: Pediatrics (Evanston) Vol. 152; no. 3; p. 1
• Main Authors: Jonat, Brian, Geneslaw, Andrew S., Capone, Christine A., Shah, Sareen, Bartucca, Lisa, Sewell, Taylor B., Acker, Karen P., Mitchell, Elizabeth, Cheung, Eva W.
• Format: Journal Article
• Language: English
• Published: United States American Academy of Pediatrics 01.09.2023
• Subjects: Child; Children; Coronaviruses; COVID-19; Glucocorticoids; Glucocorticoids - therapeutic use; Humans; Immunoglobulins; Immunoglobulins, Intravenous - therapeutic use; Inflammation; Intravenous administration; Length of stay; Multisystem inflammatory syndrome in children; Patients; Pediatrics; Retrospective Studies; Severe acute respiratory syndrome coronavirus 2

Multisystem inflammatory syndrome in children (MIS-C) is a severe hyperinflammatory illness occurring after severe acute respiratory syndrome coronavirus 2 infection. The optimal treatment of MIS-C is unknown, although prior studies have indicated benefits of intravenous immunoglobulin (IVIG) and gl...